Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography

Journal of Clinical Investigation

Volumn 98, Issue 9, 1996, Pages 2094-2099

  Paternostro, Giovanni ^a   Camici, Paolo G ^a   Lammerstma, Adriaan A ^a   Marinho, Norma ^a   Baliga, Ragavendra R ^a   Kooner, Jaspai S ^a   Radda, George K ^b   Ferrannini, Ele ^c  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

coronary heart disease; insulin resistance; myocardial muscle; skeletal muscle

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLUORODEOXYGLUCOSE F 18; GLUCOSE; INSULIN; NITRATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; GLUCOSE TRANSPORT; HEART MUSCLE BLOOD FLOW; HUMAN; INSULIN INFUSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; MALE; MEDICAL RECORD; MUSCLE BLOOD FLOW; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; SKELETAL MUSCLE;

EID: 0029910598     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119015     Document Type: Article

References (65)

1. Reaven, G.M. 1988. Role of insulin resistance in human disease. Diabetes. 37:1595-607.
2. Opie, L.H. 1991. The Heart, Physiology and Metabolism. Raven Press, New York.
3. Coleman, G.M., S. Gradinac, H. Taegtmeyer, M. Sweeney, and O.H. Frazier. 1989. Efficacy of metabolic support with glucose-insulin-potassium for left ventricular pump failure after aortocoronary bypass surgery. Circulation. 80: 191-196.
4. Oliver, M.F., and L.H. Opie. 1994. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet. 343:155-158.
5. Ferrannini, E., D. Santoro, R. Bonadonna, A. Natali, O. Parodi, and P.G. Camici. 1993. Metabolic and hemodynamic effects of insulin on human hearts. Am. J. Physiol. 264:E308-E315.
6. Rogers, W.J., R.O. Russell, Jr., H.G. McDaniel, and C.E. Rackley. 1977. Acute effects of glucose-insulin-potassium infusion on myocardial substrates, coronary blood flow and oxygen consumption in man. Am. J. Cardiol. 40:421-428.
7. Scheuer, J. 1993. Metabolic factors in myocardial failure. Circulation. 87: VII54-VII57.
8. Swan, J.W., C. Walton, I.F. Godsland, A.L. Clark, A.J. Coats, and M.F. Oliver. 1994. Insulin resistance in chronic heart failure. Eur. Heart J. 15:1528-1532.
9. Sun, D., N. Nguyen, T.R. DeGrado, M. Schwaiger, and F.C.R. Brosius. 1984. Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes. Circulation. 89: 793-798.
10. Nuutila, P., J. Knuuti, U. Ruotsalainen, V.A. Koivisto, E. Eronen, M. Teras, J. Bergman, M. Haaparanta, L. Voipio-Pulkki, and J. Viikari, et al. 1993. Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes. Am. J. Physiol. 264:E756-762.
11. vom Dahl, J., W.H. Herman, R.J. Hicks, F.J. Ortiz Alonso, K.S. Lee, K.C. Allman, E.R. Wolfe, Jr., V. Kalff, and M. Schwaiger. 1993. Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed quantitatively by dynamic positron emission tomography. Circulation. 88:395-404.
12. Voipio Pulkki, L.M., P. Nuutila, M.J. Knuuti, U. Ruotsalainen, M. Haaparanta, M. Teras, U. Wegelius, and V.A. Koivisto. 1993. Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography. J. Nucl. Med. 34:2064-2067.
13. Nuutila, P., M. Maki, H. Laine, M.J. Knuuti, U. Ruotsalainen, M. Luotolahti, M. Haaparanta, O. Solin, A. Jula, V.A. Koivisto, et al. 1995. Insulin action on heart and skeletal muscle glucose uptake in essential hypertension. J. Clin. Invest. 96:1003-1009.
14. Hicks, R.J., W.H. Herman, V. Kalff, E. Molina, E.R. Wolfe, G. Hutchins, and M. Schwaiger. 1991. Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography. J. Am. Coll. Cardiol. 18:101-111.
15. Zaret, B.L., F.J. Wackers. 1993. Nuclear cardiology (2). N. Engl. J. Med. 329:855-863.
16. DeFronzo, R.A., J.D. Tobin, and R. Andres. 1979. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237:E214-E223.
17. Spinks, T.J., T. Jones, M.C. Gilardi, and J.D. Heather. 1988. Physical performance of the latest generation of commercial positron scanner. IEEE Trans. Nucl. Med. NS-35:721-725.
18. Araujo, L.I., A.A. Lammertsma, C.G. Rhodes, E.O. McFalls, H. Iida, E. Rechavia, A. Galassi, R. De Silva, T. Jones, and A. Maseri. 1991. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation. 83:875-885.
19. 11C]deprenyl and dynamic positron emission tomography. J. Cereb. Blood Flow Metab. 11:545-556.
20. Patlak, C.S., R.G. Blasberg, and J.D. Fenstermacher. 1983. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 3:1-7.
21. Wilson, C.B.J.H., A.A. Lammerstma, C.G. McKenzie, K. Sikora, and T. Jones. 1992. Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: a rapid and non-invasive dynamic method. Cancer Res. 52:1592-1597.
22. 18F]fluoro-D-glucose transport and phosphorylation rates in myocardium using dual-tracer kinetic experiments. FEBS Lett. 216:128-132.
23. Krivokapich, J., S.C. Huang, C.E. Selin, and M.E. Phelps. 1987. Fluorodeoxyglucose rate constants, and glucose metabolic rate in rabbit heart. Am. J. Physiol. 252:H777-787.
24. 18F]fluorodeoxyglucose kinetic model in calculations of myocardial glucose metabolism during ischemia. J. Nucl. Med. 24:1060-1064.
25. Ratib, O., M.E. Phelps, S.C. Huang, E. Henze, C.E. Selin, and H.R. Schelbert. 1982. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J. Nucl. Med. 23:577-586.
26. 1BF]2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake. Circulation. 91:2435-2444.
27. Russell, R.R., J.M. Mrus, J.I. Mommessin, and H. Taegtmeyer. 1992. Compartmentation of hexokinase in rat heart. A critical factor for tracer kinetic analysis of myocardial glucose metabolism. J. Clin. Invest. 90:1972-1977.
28. Gambhir, S.S., M. Schwaiger, S.C. Huang, J. Krivokapich, H.R. Schelbert, C.A. Nienaherr, and M.E. Phelps. 1989. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J. Nucl. Med. 30:359-366.
29. 18F]fluoro-2-deoxy-D-glucose. Am. J. Physiol. 259: H1022-H1031.
30. Bonadonna, R.C., M.P. Saccomani, L. Seely, K.S. Zych, E. Ferrannini, C. Cobelli, and R.A. DeFronzo. 1993. Glucose transport in human skeletal muscle. The in vivo response to insulin. Diabetes. 42:191-198.
31. Kelley, D.E., and L.J. Mandarino. 1990. Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in non-insulin-dependent diabetes mellitus. J. Clin. Invest. 86:1999-2007.
32. Ebeling, P., R. Bourey, L. Koranyi, J.A. Tuominen, L.C. Groop, J. Henriksson, M. Mueckler, A. Sovijärvi, and V.A. Koivisto. 1993. Mechanism of enhanced insulin sensitivity in athletes. J. Clin. Invest. 92:1623-1631.
33. Natali, A., G. Buzzigoli, S. Taddei, D. Santoro, M. Cerri, R. Pedrinelli, and E. Ferrannini. 1990. Effects of insulin on hemodynamics and metabolism in human forearm. Diabetes. 39:490-500.
34. DeFronzo, R.A., E. Jacot, E. Jequier, E. Maeder, J. Wahren, and J.P. Felber. 1981. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes. 30:1000-1007.
35. Yki-Järvinen, H., A.A. Young, C. Lamkin, and J.E. Foley. 1987. Kinetics of glucose disposal in whole body and across the forearm in man. J. Clin. Invest. 79:1713-1719.
36. Mitrakou, A., D.E. Kelley, T. Veneman, T. Jenssen, T. Pangburn, J. Reilly, and J. Gerich. 1990. Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes. 39:1381-1390.
37. Iida, H., C.G. Rhodes, R. de Silva, Y. Yamamoto, L.I. Araujo, A. Maseri, and T. Jones. 1991. Myocardial tissue fraction-correction for partial volume effects and measure of tissue viability. J. Nucl. Med. 32:2169-2175.
38. Wingard, D.L., and E. Barrett-Connor. 1995. Heart disease and diabetes. In Diabetes in America, 2nd ed. NIH Publication No. 95-1468, Bethesda, MD. 429-448.
39. Fontbonne, A. 1994. Why can high insulin levels indicate a risk for coronary heart disease? Diabetologia. 37:953-955.
40. Jarrett, R.J. 1994. Why is insulin not a risk for coronary heart disease? Diabetologia. 37:945-947.
41. Reaven, G.M., and A. Laws. 1994. Insulin resistance, compensatory hyperinsulinemia, and coronary heart disease. Diabetologia. 37:948-952.
42. Stern, M.P. 1994. The insulin resistance syndrome: the controversy is dead, long live the controversy! Diabetologia. 37:956-958.
43. Despres, J.-P., B. Lamarche, P. Mauriege, B. Cantin, G.R. Dagenais, S. Moorjani, and P.-J. Lupien. 1996. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N. Engl. J. Med. 334:952-957.
44. Paolisso, G., A. Gambardella, D. Galzerano, A. D'Amore, V. Balbi, M. Varricchio, and F. D'Onofrio. 1993. Metabolic features of patients with and without coronary heart disease hut with superimposable cluster of cardiovascular risk factors. Coron. Artery. Dis. 4:1085-1091.
45. Bressler, P., S.R. Bailey, M. Matsuda, and R.A. DeFronzo. Insulin resistance and coronary heart disease. Diabetologia. In press.
46. Swan, J.W., C. Walton, I.F. Godsland, and A.L. Clark. 1994. Relationship of insulin resistance to the severity and etiology of chronic heart failure. Circulation. 90:I-174.
47. 31P nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure. Am. J. Cardiol. 60:309-315.
48. Baliga, R., A. Lammertsma, C. Rhodes, T. Aitman, J. Scott, and J.S. Kooner. 1995. Positron emission tomography localises insulin resistance to skeletal muscle in premature coronary disease. Circulation. 92:1-16.
49. Paternostro, G., K. Clarke, J. Health, A.M. Seymour, and J.K. Radda. 1995. Decreased GLUT-4 mRNA content and insulin-sensitive deoxyglucose uptake show insulin resistance in the hypertensive rat heart. Cardiovasc. Res. 30:205-211.
50. Paolisso, G., A. Gambardella, D. Galzerano, A. D'Amore, P. Rubino, M. Verza, P. Teasuro, M. Varricchio, and F. D'Onofrio. 1994. Total-body and myocardial substrate oxidation in congestive heart failure. Metab. Clin. Exp. 43: 174-179.
51. Thomas, J.A., and B.H. Marks. 1978. Plasma norepinephrine in congestive heart failure. Am. J. Cardiol. 41:233-243.
52. Marangou, A.G., F.P. Alford, G. Ward, F. Liskaser, P.M. Aitken, K.M. Weber, R.C. Boston, and J.D. Best. 1988. Hormonal effects of norepinephrine on acute glucose disposal in humans: a minimal model analysis. Metab. Clin. Exp. 37:885-891.
53. Nuutila, P., V.A. Koivisto, J. Knuuti, U. Ruotsalainen, M. Teras, et al., 1992. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J. Clin. Invest. 89:1767-1774.
54. Randle, P.J., P.B. Garland, C.N. Hales, and E.A. Newsholme. 1963. The glucose fatty-acid cycle: its role in insulin sensitivity and metabolic disturbances of diabetes mellitus. Lancet. 1:785-789.
55. Devlin, J.T. 1992. Effects of exercise on insulin sensitivity in humans. Diabetes Care. 15(Suppl.4):1690-1693.
56. Annuzzi, G., G. Riccardi, B. Capaldo, and L. Kaijser. 1991. Increased insulin-stimulated glucose uptake by exercised human muscle one day after prolonged physical exercise. Eur. J. Clin. Invest. 21:6-12.
57. Hardin, D.S., B. Azzarelli, J. Edwards, J. Wigglesworth, L. Maianu, G. Brechtel, A. Johnson, A. Baron, and W.T. Garvey. 1995. Mechanisms of enhanced insulin sensitivity in endurance-trained athletes: effects on blood flow and differential expression of GLUT4 in skeletal muscles. J. Clin. Endocrinol. Metab. 80:2437-2446.
58. Sullivan, M.J., and M.H. Hawthorne. 1995. Exercise intolerance in patients with chronic heart failure. Prog. Cardiovasc. Dis. 38:1-22.
59. Massie, B., M. Conway, R. Yonge, S. Frostick, J. Ledingham, et al., 1987. Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. Circulation. 76:1009-1019.
60. Reading, J.L., J.M. Goodman, M.J. Plyley, J.S. Floras, P.P. Liu, et al., 1993. Vascular conductance and aerobic power in sedentary and active subjects and heart failure patients. J. Appl. Physiol. 74:567-573.
61. Wilson, J.R., J.L. Martin, D. Schwartz, and N. Ferraro. 1984. Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle. Circulation. 69:1079-1087.
62. Zelis, R., S.H. Nellis, J. Longhurst, G. Lee, and D.T. Mason. 1975. Abnormalities in the regional circulations accompanying congestive heart failure. Prog. Cardiovasc. Dis. 18:181-199.
63. Opie, L.H. 1995. Glucose and the metabolism of ischaemic myocardium. Lancet 345:1520-1521.
64. Taegtmeyer, H. 1995. Is there a rationale for glucose-insulin-potassium therapy in acute myocardial infarction? Cardiol. Rev. 3:307-313.
65. Malmberg, K., and L. Ryden. 1994. Insulin-glucose infusion in diabetic patients with acute myocardial infarction reduces longterm mortality. Circulation. 90:I-168.